In contrast, the placebo group lost 3.7% of body weight
The incidence of adverse reactions, including nausea, vomiting, headache, and mild gastric discomfort, was recorded and compared between the two groups during the treatment period
Please schedule an appointment with a doctor for a detailed examination and information
When administered via weekly subcutaneous injection, tirzepatide enhances insulin secretion in response to elevated blood glucose, suppresses inappropriate glucagon release, slows gastric emptying, and promotes satiety through central nervous system pathways
Despite the high risk of fasting with diabetes and being exempted by religious rules, many Muslims fast during Ramadan
I started a weight loss program